FY24: Logistics & IT, digital innovation shine bright

12/03/25 -"Galenica reported a strong FY 2024 performance, with sales increasing by 4.7%, driven by growth across all segments except ‘at-home’ pharmacies. Adjusted EBIT increased by 10.3%, ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

12/03/25

Download

You may also be interested by these reports :

18/02/26

Idea Kicker

Currys (ADD; UK) has emerged as one of the most compelling recovery stories in European retail. The share price has more than doubled since we last ...

16/02/26

Currys

We are turning more constructive on Currys, following a stronger-than-expected performance during the peak trading period. The outperformance was ...

12/02/26

Rexel

Rexel reported Q4 2025 sales in line with market expectations. The group’s organic growth was supported by solid volumes and improved pricing. North ...

12/02/26

Fielmann Group

Mixed prel. FY25 results: Sales below but adj. EBITDA met expectations

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue